Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Ordinary shares, par value NIS 0.0000769 per share
-
Shares outstanding
-
45.5M
-
Number of holders
-
21
-
Total 13F shares, excl. options
-
9.19M
-
Shares change
-
-1.02M
-
Total reported value, excl. options
-
$17.7M
-
Value change
-
-$1.95M
-
Number of buys
-
8
-
Number of sells
-
-8
-
Price
-
$1.92
Significant Holders of Entera Bio Ltd. - Ordinary shares, par value NIS 0.0000769 per share (ENTX) as of Q3 2025
23 filings reported holding ENTX - Entera Bio Ltd. - Ordinary shares, par value NIS 0.0000769 per share as of Q3 2025.
Entera Bio Ltd. - Ordinary shares, par value NIS 0.0000769 per share (ENTX) has 21 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 9.19M shares
of 45.5M outstanding shares and own 20.21% of the company stock.
Largest 10 shareholders include Knoll Capital Management, LLC (5.88M shares), Point72 Asset Management, L.P. (1.18M shares), MARSHALL WACE, LLP (627K shares), Schonfeld Strategic Advisors LLC (567K shares), Parkman Healthcare Partners LLC (281K shares), NORTHERN TRUST CORP (149K shares), BESSEMER GROUP INC (141K shares), RENAISSANCE TECHNOLOGIES LLC (88.4K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (67.2K shares), and SIGNATURE ESTATE & INVESTMENT ADVISORS LLC (47.3K shares).
This table shows the top 21 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.